KMT2A and acute myeloid leukemia: AML cell lines with high GAS6/AXL expression and MLL/FLT3-ITD mutations (MV4-11, MOLM-13), exhibited greater sensitivity to SLC-391 than cell lines with low GAS6/AXL expression and no MLL/FLT3-ITD mutations.